Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS - PubMed (original) (raw)

. 2014 Jan 14;111(2):829-32.

doi: 10.1073/pnas.1314085111. Epub 2013 Dec 30.

Laura Ferraiuolo, Carlos J Miranda, Shibi Likhite, Sohyun McElroy, Samantha Renusch, Dara Ditsworth, Clotilde Lagier-Tourenne, Richard A Smith, John Ravits, Arthur H Burghes, Pamela J Shaw, Don W Cleveland, Stephen J Kolb, Brian K Kaspar

Affiliations

Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS

Kathrin Meyer et al. Proc Natl Acad Sci U S A. 2014.

Abstract

Amyotrophic lateral sclerosis (ALS) causes motor neuron degeneration, paralysis, and death. Accurate disease modeling, identifying disease mechanisms, and developing therapeutics is urgently needed. We previously reported motor neuron toxicity through postmortem ALS spinal cord-derived astrocytes. However, these cells can only be harvested after death, and their expansion is limited. We now report a rapid, highly reproducible method to convert adult human fibroblasts from living ALS patients to induced neuronal progenitor cells and subsequent differentiation into astrocytes (i-astrocytes). Non-cell autonomous toxicity to motor neurons is found following coculture of i-astrocytes from familial ALS patients with mutation in superoxide dismutase or hexanucleotide expansion in C9orf72 (ORF 72 on chromosome 9) the two most frequent causes of ALS. Remarkably, i-astrocytes from sporadic ALS patients are as toxic as those with causative mutations, suggesting a common mechanism. Easy production and expansion of i-astrocytes now enables rapid disease modeling and high-throughput drug screening to alleviate astrocyte-derived toxicity.

Keywords: neurodegeneration; neurotoxicity; reprogramming.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1.

Fig. 1.

Direct conversion of human skin fibroblasts to tripotent iNPCs. (A) Schematic of the conversion process from fibroblasts to induced neuronal progenitor cells (iNPCs). Fibroblasts were transduced with retroviral vectors containing four reprogramming factors (Sox2, KLF4, Oct3/4, c-Myc). (B and C) Within 6–10 d, cells underwent marked morphological changes from a fibroblastic spindle like shape (B) to a sphere-like form commonly seen with NPCs (C). (D and E) Immunofluorescence of cultures at day 12 reveals expression of the NPC markers Pax6 and Nestin, as shown in red. DAPI staining (blue) was used to visualize nuclei. (F) iNPCs can form and grow as neurospheres when plated in uncoated dishes. (G) RT-PCR analysis demonstrates a strong up-regulation of the prototypic NPC markers NCAN and NKX2-2 in iNPCs. β-Actin was used as loading control. (H–J) iNPCs are tripotent and upon differentiation they can give rise to oligodendrocytes (H), neurons (I), and astrocytes (J). (Scale bars: black, 100 µm; white, 50 μm.) Fibro, fibroblast.

Fig. 2.

Fig. 2.

I-astrocytes express prototypic astrocyte markers. (A) Immunofluorescence analysis reveals strong up-regulation of astrocytic markers such as Vimentin, CD44, S100β, and GFAP in i-astrocytes compared with the initial fibroblasts. DAPI (blue) was used to visualize nuclei. (B) RT-PCR analysis revealed expression of IGFB3 in fibroblasts, iNPCs, and i-astrocytes, whereas expression of S100β and Aqp4 was detected in iNPCs and i-astrocytes or i-astrocytes only, respectively. (Scale bar: 100 μm.) Fibro, fibroblast. i-Astro, i-astrocytes.

Fig. 3.

Fig. 3.

I-astrocytes from fALS and sALS patients display toxicity toward MNs. (A) Representative images after 96 h of coculture of HB9-GFP expressing MNs (shown in black) with astrocytes from spinal cord (sc) or skin of ALS patients and controls. A marked loss of MN viability was observed in the presence of ALS astrocytes irrespective of their origin (spinal cord or skin). (B) Relative percentage of MN survival after 96 h of coculture with ALS astrocytes derived from spinal cord or skin and their respective controls. ***P < 0.001; ****P < 0.0001 [compared with the average taken from of all converted control lines (HDFA, 8620, 155, 170)]. Error bars represent SEM. Quantification was performed in triplicate wells of a 96-well plate, and data are representative of n = 5.

Similar articles

Cited by

References

    1. Ferraiuolo L, Kirby J, Grierson AJ, Sendtner M, Shaw PJ. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat Rev Neurol. 2011;7(11):616–630. - PubMed
    1. DeJesus-Hernandez M, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011;72(2):245–256. - PMC - PubMed
    1. Renton AE, et al. ITALSGEN Consortium A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–268. - PMC - PubMed
    1. Di Giorgio FP, Boulting GL, Bobrowicz S, Eggan KC. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell. 2008;3(6):637–648. - PubMed
    1. Haidet-Phillips AM, et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol. 2011;29(9):824–828. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources